No Data
Express News | UBS Group: Lowered the Target Price for Novo-Nordisk A/S from 700 Danish kroner to 600 Danish kroner.
10 Health Care Stocks Whale Activity In Today's Session
Shaping a new paradigm of Digital Health Medical Services, Ark Health (06086) has launched a glucose-lowering version of Semaglutide.
In the future, the company will continue to promote the integration and innovation of digital intelligence and Digital Health service scenarios, and establish Global Strategy partnerships with leading CNI Biomedicine Index enterprises worldwide.
Global Equities Roundup: Market Talk
Novo Nordisk Faces Several Questions on Wegovy -- Market Talk
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy(R)- Hagens Berman